Company profile for CV Science

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil is the top-selling brand of hemp-derived CBD on the market, according to SPINS...
CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10070 Barnes Canyon Rd. San Diego, CA 92121
Telephone
Telephone
1-855-PLUS-CBD
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cv-sciences-inc-to-announce-year-end-and-fourth-quarter-2024-results-1002646

ACCESSWIRE
20 Mar 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cv-sciences-unveils-new-aura-collection-thc-fizz-tablets-979711

ACCESSWIRE
05 Feb 2025

https://www.globenewswire.com/news-release/2022/03/08/2399054/0/en/CV-Sciences-Adds-PlusCBD-Relief-Softgels-to-Wellness-Line-of-CBD-Products.html

GLOBENEWSWIRE
08 Mar 2022

https://www.globenewswire.com/news-release/2021/08/05/2275544/0/en/CV-Sciences-Inc-to-Announce-Second-Quarter-2021-Results-on-August-12-2021.html

GLOBENEWSWIRE
05 Aug 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty